Yes, there is a pill form of semaglutide, the same active ingredient in Ozempic. It’s called Rybelsus, and it’s been FDA-approved since 2019. Both medications are made by Novo Nordisk and work the same way in your body, but Rybelsus is a daily tablet while Ozempic is a once-weekly injection. Rybelsus is currently approved for type 2 diabetes, not weight loss, which is an important distinction if weight management is your primary goal.
Rybelsus vs. Ozempic: Key Differences
Rybelsus and Ozempic contain the same drug, semaglutide, a GLP-1 receptor agonist that helps regulate blood sugar and reduces appetite. The difference is how they get into your bloodstream. Ozempic is injected under the skin once a week, where the drug is absorbed directly. Rybelsus is swallowed as a tablet once every day.
Getting a protein-based drug like semaglutide past stomach acid and into the bloodstream is genuinely difficult. Stomach enzymes normally destroy these molecules before they can be absorbed. Rybelsus solves this by co-formulating semaglutide with a compound called SNAC, a small fatty acid that temporarily increases the permeability of the stomach lining in a tiny area right around where the tablet dissolves. SNAC also neutralizes stomach acid locally, protecting the semaglutide from being broken down. It’s a clever workaround, but it comes with strict rules about how you take the pill.
In terms of weight loss, both versions produce meaningful results. An observational study found that patients on either Rybelsus or Ozempic lost similar amounts of weight, around 6 kg (about 13 pounds) after six months. In separate clinical trials, Rybelsus users lost up to 3.7 kg over 26 weeks, while Ozempic users lost up to 4.7 kg over 30 weeks. No head-to-head randomized trial has directly compared weight loss between the two.
How to Take the Pill Correctly
Rybelsus has some of the most specific dosing instructions of any oral medication, and following them matters. If you take the pill wrong, your body absorbs significantly less of the drug.
You need to take Rybelsus first thing in the morning on a completely empty stomach, with no more than 4 ounces of plain water. No coffee, no juice, no other beverages. After swallowing the tablet, you must wait at least 30 minutes before eating, drinking anything else, or taking other medications. Swallow the tablet whole. Do not crush, split, or chew it.
Taking Rybelsus with food, other drinks, or other pills reduces how much semaglutide your body absorbs. Waiting longer than 30 minutes to eat can actually increase absorption. This daily routine is the main trade-off compared to Ozempic’s once-weekly injection, and it’s worth considering which fits better into your life.
Available Doses and How Treatment Starts
Rybelsus comes in three tablet strengths: 3 mg, 7 mg, and 14 mg. Treatment starts at the lowest dose to let your body adjust, then increases over time. You’ll typically begin at 3 mg daily for the first 30 days, move up to 7 mg, and potentially reach 14 mg depending on how your blood sugar responds and how well you tolerate the medication.
For comparison, Ozempic is available in 0.25 mg, 0.5 mg, 1 mg, and 2 mg doses given weekly. The numbers look very different because most of the oral tablet is destroyed in digestion. Only a small fraction of the semaglutide in each Rybelsus pill actually reaches your bloodstream, which is why the milligram amounts are so much higher.
Side Effects Are Similar to the Injection
Because both medications contain semaglutide, the side effect profile is largely the same. The most common issues are gastrointestinal: nausea, vomiting, diarrhea, abdominal pain, and constipation. These tend to be worst when you first start or when your dose increases, and they typically ease over the first few weeks.
Other reported effects include bloating, gas, indigestion, heartburn, burping, and acid reflux. Loss of appetite is common too, and it’s actually part of how the drug helps with weight and blood sugar control. Most of these side effects are mild, but some people find the GI symptoms uncomfortable enough to stop treatment or stay at a lower dose.
Cost and Availability
Rybelsus is not cheap. Without insurance, a 30-day supply of the 3 mg tablet runs around $1,012 at retail pricing. Ozempic’s retail cost is in a similar range. Whether insurance covers one, both, or neither depends entirely on your plan, your diagnosis, and your insurer’s formulary. Some plans cover the injection but not the oral version, or vice versa.
If cost is a concern, it’s worth checking both options with your insurance provider. Novo Nordisk offers savings cards for both medications that can reduce out-of-pocket costs for commercially insured patients.
A Higher-Dose Pill May Be Coming
The current Rybelsus doses top out at 14 mg, which delivers less semaglutide to the bloodstream than the higher Ozempic injection doses. But a 50 mg oral semaglutide tablet has been tested in a large phase 3 clinical trial called OASIS 1, with impressive results.
In that trial, participants with overweight or obesity who took the 50 mg oral dose lost an average of 15.1% of their body weight over 68 weeks, compared to 2.4% with placebo. More than half of participants (54%) lost at least 15% of their body weight, and about a third lost 20% or more. Those numbers are competitive with injectable semaglutide at the doses used for weight management. If approved, a higher-dose oral option could close the gap between the pill and the injection for people seeking weight loss specifically.
For now, Rybelsus at its current doses is approved only for type 2 diabetes. Ozempic carries the same indication, though its higher-dose sibling Wegovy (also semaglutide) is specifically approved for weight management. If your primary interest is a semaglutide pill for weight loss rather than diabetes, that product doesn’t exist yet, but it may not be far off.